Approval from the European Medical Devices Regulation has been given to a screening tool which uses artificial intelligence to select embryos for IVF transfer.
The newly CE marked tool comes from Israel-based Fairtility, which claims that its embryo selection tool selects the embryo with the most developmental potential for transfer in 78 percent of cases, compared to professional embryologists who make the right selection 60 percent of the time.
The company published results from its own trial in Scientific Reports in February this year, and says it plans to seek approval from the Food and Drug Administration in the USA next year, Times of Israel reported.
